Weight Loss & Metabolic

This category contains research compounds investigated in the context of metabolic regulation, energy homeostasis, adipose tissue biology, and insulin-incretin signalling pathways. The GLP-1 receptor agonist class — including Semaglutide, Tirzepatide, and Retatrutide — represents some of the most actively published research in contemporary molecular pharmacology, with studies spanning glucose metabolism, central appetite signalling, and cardiovascular biology. Also included are GH fragment analogues such as AOD-9604, studied in adipose tissue lipolysis models, and small molecule NNMT inhibitors investigated in adipogenesis research. These compounds are tools for researchers working in endocrinology, obesity biology, metabolic disease modelling, and related in-vitro study contexts.

For laboratory and in-vitro research purposes only. Not intended for human or animal consumption. Not pharmaceutical products. These compounds are not approved for therapeutic use and do not constitute medical advice.